News & Press Release

  • All Categories
  • Announcements
  • HR and Organization
  • Product Information
    • 2015-12-24 Announcements Our president, Jin Shiomura, invited to participate in the “Council for Promotion of Ventures driving the Medical Innovation” organized by MHLW
    • 2015-12-24 Announcements The presentation at the symposium “Cutting Edge of Drug Discovery by AIST” on the research outcome through collaboration with AIST (Advanced Industrial Science and Technology) introduced on Nikkei Sangyo Shimbun
    • 2015-12-20 Announcements An article on the cooperative efforts with the patient group for our development of sirolimus (NPC-12G) in Nihon Keizai Shimbun
    • 2015-12-18 Product Information Sirolimus (NPC-12G) received orphan drug designation by MHLW
    • 2015-10-28 Product Information Sirolimus (NPC-12G) received the first “SAKIGAKE” designation under the “SAKIGAKE” fast-track review system by the Ministry of Health, Labour and Welfare
    • 2015-07-30 Announcements Press Seminar “Gastroenteropancreatic Neuroendocrine Tumor and the New Drug, Zanosar” presented
    • 2015-02-27 Announcements Nobelpharma won “The japan Academic Society of Venture and Entrepreneurs Award” at the 9th Japan Bio Venture Awards
    • 2015-02-23 Product Information Launch of Nobelzin® Tablets 25 mg and 50 mg for Wilson’s disease
    • 2015-02-23 Product Information Launch of Zanosar® Intravenous Infusion 1 g, an anti-cancer (gastroenteropancreatic neuroendocrine tumor) drug
  1. HOME
  2. News & Press Release